Pharmacokinetic studies in patients on continuous renal replacement therapies

Intensive Care Medicine

Volumn 27, Issue 4, 2001, Pages 629-630

  Kroh, U F ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CIPROFLOXACIN;

ACUTE KIDNEY FAILURE; ALGORITHM; DEVICE; DOSE RESPONSE; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG EFFICACY; EDITORIAL; HEMODIALYSIS; HUMAN; INFECTION; INTENSIVE CARE; KIDNEY FUNCTION; PERFORMANCE; SAFETY; STEADY STATE;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; HUMANS; INTENSIVE CARE UNITS; KIDNEY FAILURE, ACUTE; RENAL REPLACEMENT THERAPY;

EID: 0035052949     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340100908     Document Type: Editorial

References (9)

1. A primer on continuous renal replacement therapy for critically ill patients
2. Pharmacokinetic principles during continuous renal replacement therapy: Drugs and dosage
3. Drug administration in critically ill patients with acute renal failure
4. Pharmacokinetics of ciprofloxacin in ICU patients on continuous veno-venous hemodiafiltration
5. Adaptive control of therapeutic drug regimen relations between clinical situations: Outcomes and simulations using nonlinear dynamic models
6. Antimicrobial action and pharmacokinetics/pharmacodynamics: The use of AUIC to improve efficacy and avoid resistance
7. Population pharmacokinetics/pharmacodynamics modeling: Parametric and nonparametric methods
8. A pharmacokinetic/pharmacodynamic comparison of SAAM II and PC/WinNonlin modeling software